This guideline replaces Guideline on Modified Release Oral and Transdermal Dosage Forms Section II 9 (Pharmacokinetic and Clinical Evaluation (EMA/CPMP/EWP/280/96 Corr*)).
| Download document | Draft guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms (EMA/CPMP/EWP/280/96 Corr1) |
|---|---|
| Reference number | EMA/CHMP/EWP/280/96 Rev.1 |
| Status | draft: consultation open |
| First published | 15/03/2013 |
| Last updated | 15/03/2013 |
| Consultation start date | 15/03/2013 |
| Consultation end date | 15/09/2013 |
| Email address for submissions | PKWPsecretariat@ema.europa.eu |